Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison Study of ADC189 Bioavailability Between Tablet and Granule in Healthy Chinese Adult Male Subjects, and the Safety and Pharmacokinetics of Ultra-high Dose ADC189

NCT06428903 is registered in ClinicalTrials.gov with Jiaxing AnDiCon Biotech Co.,Ltd as lead sponsor.

NCT NCT06428903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06428903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison Study of ADC189 Bioavailability Between Tablet and Granule in Healthy Chinese Adult Male Subjects, and the Safety and Pharmacokinetics of Ultra-high Dose ADC189
Lead sponsor
Jiaxing AnDiCon Biotech Co.,Ltd
Phase
Phase 1
Overall status
Completed
Start date
March 12, 2024
Completion date
September 22, 2024
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteer